532 related articles for article (PubMed ID: 28758577)
1. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases.
Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A
Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 90 in Alzheimer's disease.
Ou JR; Tan MS; Xie AM; Yu JT; Tan L
Biomed Res Int; 2014; 2014():796869. PubMed ID: 25374890
[TBL] [Abstract][Full Text] [Related]
3. Protective role of heat shock proteins in Parkinson's disease.
Aridon P; Geraci F; Turturici G; D'Amelio M; Savettieri G; Sconzo G
Neurodegener Dis; 2011; 8(4):155-68. PubMed ID: 21212626
[TBL] [Abstract][Full Text] [Related]
4. Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain.
Thirstrup K; Sotty F; Montezinho LC; Badolo L; Thougaard A; Kristjánsson M; Jensen T; Watson S; Nielsen SM
Pharmacol Res; 2016 Feb; 104():197-205. PubMed ID: 26731018
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.
Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
J Mol Med (Berl); 2006 Aug; 84(8):635-46. PubMed ID: 16741751
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 90 in neurodegenerative diseases.
Luo W; Sun W; Taldone T; Rodina A; Chiosis G
Mol Neurodegener; 2010 Jun; 5():24. PubMed ID: 20525284
[TBL] [Abstract][Full Text] [Related]
7. Heat Shock Proteins in Alzheimer's Disease: Role and Targeting.
Campanella C; Pace A; Caruso Bavisotto C; Marzullo P; Marino Gammazza A; Buscemi S; Palumbo Piccionello A
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200516
[TBL] [Abstract][Full Text] [Related]
8. Heat Shock Protein 90 in Parkinson's Disease: Profile of a Serial Killer.
Mansour HM; Mohamed AF; Khattab MM; El-Khatib AS
Neuroscience; 2024 Jan; 537():32-46. PubMed ID: 38040085
[TBL] [Abstract][Full Text] [Related]
9. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
Kim T; Keum G; Pae AN
Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
[TBL] [Abstract][Full Text] [Related]
10. Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer.
Haque A; Alam Q; Alam MZ; Azhar EI; Sait KH; Anfinan N; Mushtaq G; Kamal MA; Rasool M
Curr Pharm Des; 2016; 22(20):2947-59. PubMed ID: 27013225
[TBL] [Abstract][Full Text] [Related]
11. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells.
Ryhänen T; Mannermaa E; Oksala N; Viiri J; Paimela T; Salminen A; Atalay M; Kaarniranta K
Eur J Pharmacol; 2008 Apr; 584(2-3):229-36. PubMed ID: 18313664
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 modulation for the treatment of Alzheimer's disease.
Zhao H; Michaelis ML; Blagg BS
Adv Pharmacol; 2012; 64():1-25. PubMed ID: 22840743
[TBL] [Abstract][Full Text] [Related]
13. [Thermosensitization of tumor cells with inhibitors of chaperone activity and expression].
Kudriavtsev VA; Makarova IuM; Kabakav AE
Biomed Khim; 2012; 58(6):662-72. PubMed ID: 23350198
[TBL] [Abstract][Full Text] [Related]
14. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
[TBL] [Abstract][Full Text] [Related]
15. The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells.
Schaefer S; Svenstrup TH; Guerra B
PLoS One; 2017; 12(5):e0177706. PubMed ID: 28542269
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
Bohush A; Bieganowski P; Filipek A
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
[TBL] [Abstract][Full Text] [Related]
17. The heat shock protein 90 chaperone complex: an evolving therapeutic target.
Barginear MF; Van Poznak C; Rosen N; Modi S; Hudis CA; Budman DR
Curr Cancer Drug Targets; 2008 Sep; 8(6):522-32. PubMed ID: 18781898
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
[TBL] [Abstract][Full Text] [Related]
19. Low endogenous and chemical induced heat shock protein induction in a 0N3Rtau-expressing Drosophila larval model of Alzheimer's disease.
Sinadinos C; Quraishe S; Sealey M; Samson PB; Mudher A; Wyttenbach A
J Alzheimers Dis; 2013; 33(4):1117-33. PubMed ID: 23114515
[TBL] [Abstract][Full Text] [Related]
20. Updates on Aβ Processing by Hsp90, BRICHOS, and Newly Reported Distinctive Chaperones.
Iqbal M; Lewis SL; Padhye S; Jinwal UK
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
